Prostate Cancer
January 2012
Baseline Prostate-Specific Antigen Testing at a Young Age
Loeb, S, Carter, B, Catalona, WJ.
Prostate-Specific Antigen–Based Risk Assessment in Younger Men
Strope, SA, Andriole, GL.
Reply from Authors re: Seth A. Strope, Gerald L. Andriole. Prostate-Specific Antigen–Based Risk Assessment in Younger Men. Eur Urol 2012;61:8–9
Loeb, S, Carter, B, Catalona, WJ.
Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer
Pagliarulo, V, Bracarda, Eisenberger, S, Eisenberger, MA.
Hormone Therapy for Prostate Cancer: What Have We Done With Charles Huggins’ Legacy?
Tombal, B.
Best Article! Towards an Optimal Interval for Prostate Cancer Screening
van Leeuwen, P, Roobol, MJ, Kranse, R.
Best Article! Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort
Hambrock, T, Hoeks, C, Hulsbergen-van de Kaa, C.
December 2011
Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases–Free Survival Outcomes
Zelefsky, MJ, Pei, X, Chou, JF.
Improved Toxicity Profile Following High-Dose Postprostatectomy Salvage Radiation Therapy With Intensity-Modulated Radiation Therapy
Goenka, A, Magsanoc, JM, Pei, X.
Intensity-Modulated Radiotherapy: The Gold Standard for Postprostatectomy Irradiation?
Bossi, A, Meerleer, G, Ost, P.
Reply from Authors re: Alberto Bossi, Gert De Meerleer, Piet Ost. Intensity-Modulated Radiotherapy: The Gold Standard for Postprostatectomy Irradiation? Eur Urol 2011;60:1149–50
Zelefsky, MJ, Goenka, A.
November 2011
Permanent Interstitial Low-Dose-Rate Brachytherapy for Patients with Localised Prostate Cancer: A Systematic Review of Randomised and Nonrandomised Controlled Clinical Trials
Peinemann, F, Grouven, U, Bartel, C.
TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Danila, D.C, Anand, A, Sung, C.C.
Circulating Tumour Cells as Surrogate Biomarkers in Castration-Resistant Prostate Cancer Trials
Bjartell, A.
Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer
Kim, S, Shen , S, Moore, D.F.
Gastrointestinal Toxicity Following Radiotherapy for Prostate Cancer: A Ring of Fire
Linton, K.D, Catto, J.
Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based Cohort
Abdollah, F, Sun, M, Schmitges, J.
Propensity Score Matching, Competing Risk Analysis, and a Competing Risk Nomogram: Some Guidance for Urologists May Be in Place
Roobol, MJ, Heijnsdijk, E.
Reply from authors re: Monique J. Roobol, Eveline A.M. Heijnsdijk. Propensity Score Matching, Competing Risk Analysis, and a Competing Risk Nomogram: Some Guidance for Urologists May Be in Place. Eur Urol 2011;60:931–3
Sun, M, Abdollah, F, Karakiewicz, P.L.
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
Rigatti, P, Suardi, N, Briganti, A.
Salvage Lymph Node Dissection in Recurrent Prostate Cancer Patients
Stenzl, A.
October 2011
Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3 009 258 Men
Ørsted, D.D, Bojesen, S.E, Nielsen, S.F.
Associations of Benign Prostatic Hyperplasia With Prostate Cancer: The Debate Continues
Kopp, R.P, Freedland, S.J, Parsone, J.K.
Reply from Authors re: Ryan P. Kopp, Stephen J. Freedland, J. Kellogg Parsons. Associations of Benign Prostatic Hyperplasia With Prostate Cancer: The Debate Continues. Eur Urol 2011;60:699–700
Ørsted, D.D, Bojesen, S.E, Nielsen, S.F.
September 2011
Disease-Free Survival Following Salvage Cryotherapy for Biopsy-Proven Radio-Recurrent Prostate Cancer
Williams, A.K, Martínez, C.H, Lu, C.
Radiorecurrent Prostate Cancer: An Emerging and Largely Mismanaged Epidemic
Jones, S.J.
Factors Determining Functional Outcomes After Radical Prostatectomy: Robot-Assisted Versus Retropubic
Kim, S.C, Song, C, Kim, W.
Additional Evidence for Improved Functional Outcomes Following Robot-Assisted Radical Prostatectomy
Fuller, A.
Reply from Authors re: Andrew Fuller, Stephen E. Pautler. Additional Evidence for Improved Functional Outcomes Following Robot-Assisted Radical Prostatectomy. Eur Urol 2011;60:420–1
Kim, S.C, Song, C, Kim, W.
2011- August
Best Article! Impact of Venous Tumour Thrombus Consistency (Solid vs Friable) on Cancer-specific Survival in Patients with Renal Cell Carcinoma
Bertini, R, Roscigno, M, Freschi, M.
Platinum Priority! Extent of Pelvic Lymph Node Dissection and the Impact of Standard Template Dissection on Nomogram Prediction of Lymph Node Involvement
Godoy, G, Tai Chong, K, Cronin, A.
Platinum Priority! To What Extent Can We Predict Prostate Cancer Lymph Node Involvement?
Karnes, R,J,.
With Reply From Authors re: R. Jeffrey Karnes. To What Extent Can We Predict Prostate Cancer Lymph Node Involvement? Eur Urol 2011;60:202–3
Godoy, G, Coleman, J.
Platinum Priority!With Editorial Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration
Chade, D, Shariat,S, Cronin,A.
Platinum Priority! Salvage Radical Prostatectomy in 2011: An Established Therapeutic Option?
Graefen, M.
Platinum Priority! Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting
Guazzoni,, G, Nava, N, Lazzeri,, M.
Platinum Priority! Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely?
Roobol, M, J.
Platinum Priority! How to Tell If a New Marker Improves Prediction
Nguyen, C,T, Kattan, M,W.
Platinum Priority! Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223–5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction. Eur Urol 2011;60:226–8
Guazzoni, G, Nava, N, Lazzeri, M.
2011 - July
Original Articles together with the Full Length Editorials
Trends in Mortality From Urologic Cancers in Europe, 1970–2008
Bosetti, C, Bertuccio, P, Chatenoud, L.
Health Care Spending, Social Policy, Public Health, and Life Expectancy: What Cancer Outcomes Can Tell Us Beyond Treatment Efficacy
Catto, J.
Reply from Authors re: James W.F. Catto. Health Care Spending, Social Policy, Public Health, and Life Expectancy: What Cancer Outcomes Can Tell Us Beyond Treatment Efficacy. Eur Urol 2011;60:16–8
Bosetti, C, La Vecchia, C, Levi, F.
Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study
Aly, M, Wiklund, F, Xu, J.
Genetic Markers and the Risk of Developing Prostate Cancer
Bjartell, A.
2011- June
Platinum Priority! Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence
Boorjian, S, A, Thompson, R, H, Tollefson, M, K.
With the following accompanying Editorial
Natural History of Patients Presenting Biochemical Recurrence After Radical Prostatectomy: Some Good News?
Guillonneau, B, D, Fizazi, K.
Platinum Priority! Division of Autonomic Nerves Within the Neurovascular Bundles Distally into Corpora Cavernosa and Corpus Spongiosum Components: Immunohistochemical Confirmation with Three-Dimensional Reconstruction Alsaid, B, Bessede, T, Diallo, D.
With the following accompanying Editorial
Whither Go Pro-erectile Nerves of the Neurovascular Bundles?
Myers, R, P.
2011- May
Best Article!Exosomes as Biomarker Treasure Chests for Prostate Cancer
Duijvesz, D, Luider, T.
Best Article!Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2–4 pN+ Prostate Cancer: Results of a Matched Analysis
Briganti, A, Karnes, J, Da Pozzo, L.
Platinum Priority!Safety Profile of Robot-Assisted Radical Prostatectomy: A Standardized Report of Complications in 3317 Patients
Agarwal, A, Sammon, J, Bhandari, A.
With the following accompanying Editorial
Is Robot-Assisted Radical Prostatectomy Safer Than Other Radical Prostatectomy Techniques?
Marberger, M.
With the following accompanying reply
Reply from Authors re: Michael Marberger. Is Robot-Assisted Radical Prostatectomy Safer Than Other Radical Prostatectomy Techniques? Eur Urol 2011;59:699–700
Agarwal, P, Menon, M.
Platinum Priority!Pentafecta: A New Concept for Reporting Outcomes of Robot-Assisted Laparoscopic Radical Prostatectomy
Patel, V, Sivaraman, A, Coelho, R.
With the following accompanying Editorial
The Devil Is in the Details
Eastham, J, Scardino, P.
With the following accompanying reply
Reply from Authors re: James A. Eastham, Peter T. Scardino. The Devil Is in the Details. Eur Urol 2011;59:708–9
Patel, V, Sivaraman, A.
2011- April
Best Article!Bone Turnover Markers as Predictors of Mortality Risk in Prostate Cancer Patients with Bone Metastases Following Treatment with Zoledronic Acid
Jung, K, Miller, K,Wirth, M.
Best Article!The Prognostic Significance of Capsular Incision Into Tumor During Radical Prostatectomy
Preston, M, Carrière, M, Raju, G.
Platinum Priority!Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
Dickinson, Louise, Ahmed,H,U, Allen, Claire.
Platinum Priority – Editorial!Consensus Criteria for the Use of Magnetic Resonance Imaging in the Diagnosis and Staging of Prostate Cancer: Not Ready for Routine Use
Heidenreich, A.
Platinum Priority!Prostate Cancer Incidence and Disease-Specific Survival of Men with Initial Prostate-Specific Antigen Less Than 3.0 ng/ml Who Are Participating in ERSPC Rotterdam
Bul, M, van Leeuwen, PJ, Zhu, X.
Platinum Priority – Editorial!A Risk-Stratified Approach to Prostate-Specific Antigen Screening
Keto, CJ, Freedland, SJ.
Platinum Priority!Impact of 5?-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer|
Finelli, A, Trottier, G, Lawrentschuk, N.
Platinum Priority – Editorial!The Use of 5?-Reductase Inhibitors for the Prevention and Treatment of Prostate Cancer
Cha, EK, Shariat, SF.
2011 - March
Best Article!A Panel of TMPRSS2:ERG Fusion Transcript Markers for Urine-Based Prostate Cancer Detection with High Specificity and Sensitivity
Nguyen, P,N, Violette, P, Chan,S.
Best Article!The Male Rectourethralis and Deep Transverse Perineal Muscles and Their Relationship to Adjacent Structures Examined with Successive Slices of Celloidin-Embedded Pelvic Viscera
Zhai, L, Liu, J, Li, Y.
Best Article!Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
Ploussard, G, Durand, X, Xylinas, E.
Platinum Priority! Cancer Control and Functional Outcomes After Radical Prostatectomy as Markers of Surgical Quality: Analysis of Heterogeneity Between Surgeons at a Single Cancer Center
Vickers, A, Savage, C, Bianco, F.
With the following accompanying Editorial
Does the Surgeon Really Matter? Functional Results Following Radical Prostatectomy
Bastian, P.
Editorial!Is Prostate Cancer Screening Bad or Good? Summary of a Debate at the Innovation in Urology Meeting, September 17–19, 2010, Milan, Italy
Roobol, MJ.
Editorial!Is Population Screening for Prostate Cancer Good or Bad?
Clarke, NW.
Editorial!Screening for Prostate Cancer: Practical Analysis of the ESRPC and PLCO Trials
Djavan, B.
2011 - February
Best Article!Effect of Dutasteride on Prostate Biopsy Rates and the Diagnosis of Prostate Cancer in Men with Lower Urinary Tract Symptoms and Enlarged Prostates in the Combination of Avodart and Tamsulosin Trial
Roehrborn, C,G, Andriole,G, L, Wilson, T,H.
Platinum Priority! Prostate Cancer Detection and Dutasteride: Utility and Limitations of Prostate-Specific Antigen in Men with Previous Negative Biopsies
Van Leeuwen, P.J, Kölble, K, Huland, H.
With the following accompanying Editorials
Prostate Cancer Detection: A View of the Future
Thompson Jr, I,M, Leach, R,J, Ankerst, D,P.
Making an Imperfect Marker Better
Freedland, S,J, Freedland, G,L.
Platinum Priority!Olfactory Detection of Prostate Cancer by Dogs Sniffing Urine: A Step Forward in Early Diagnosis
Freedland,, J,N, Cancel-Tassin, G, Ondet, V.
With the following accompanying Editorial
Dogs Sniffing Urine: A Future Diagnostic Tool or a Way to Identify New Prostate Cancer Markers?
Bjartell, A,S.
2011 - January
Platinum Priority! A Prospective Trial Comparing Consecutive Series of Open Retropubic and Robot-Assisted Laparoscopic Radical Prostatectomy in a Centre with a Limited Caseload
Di Pierro, G, Baumeister, P.
With the following accompanying Editorial
Robot-Assisted Radical Prostatectomy: Is the Dust Settling?
Menon, M.
Best Article!Prostate Cancer Detection in the “Grey Area” of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3
Perdonà, S, Cavadas, V, Di Lorenzo, G.
Best Article!A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988–2006
Abdollah,F, Sun, M, Thuret, R.
Best Article!Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
Auprich, M, Chun, F, Ward, J.
2010
2009
